Laboratory Corporation Of America Holdings

CLIA Laboratory Citation Details

2
Total Citations
8
Total Deficiencyies
4
Unique D-Tags
CMS Certification Number 34D2028103
Address 7 Mcdowell Street, Suite 300, Asheville, NC, 28801
City Asheville
State NC
Zip Code28801
Phone(828) 254-1376

Citation History (2 surveys)

Survey - July 22, 2025

Survey Type: Standard

Survey Event ID: QLQ711

Deficiency Tags: D5413 D5413

Summary:

Summary Statement of Deficiencies D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(b) (b) The laboratory must define criteria for those conditions that are essential for proper storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (b)(1) Water quality. (b)(2) Temperature. (b)(3) Humidity. (b)(4) Protection of equipment and instruments from fluctuations and interruptions in electrical current that adversely affect patient test results and test reports. This STANDARD is not met as evidenced by: Based on observation, review of manufacturers' instructions, review of the laboratory's 2024 and 2025 temperature logs, and interview with the TS (technical supervisor) 7/22/25, the laboratory failed to define an acceptable freezer temperature range for storage of the VALIDATE linearity material and failed to ensure freezer temperatures were within manufacturer's specified acceptable limits for storage of the VALIDATE linearity material. Findings: During a tour of the laboratory at approximately 1:00 p.m., the surveyor observed VALIDATE linearity material (examples: GC1 Test Set, Fertility 1 and 2 Test Sets, GC3 Test Set, GC4 Test Set) stored with BIO-RAD Liquichek quality control material (examples: Liquichek Unassayed Chemistry Control Level 1 and Level 2, Liquichek Pediatric Control Level 2) in a small white freezer in the chemistry area. Review of manufacturer's instructions for the VALIDATE GC1 Calibration Verification / Linearity Test Kit revealed "... STORAGE AND STABILITY The VALIDATE GC1 Calibration Verification / Linearity Test Kit is stored at -10 to -25 degrees C (Celsius). ... Test kits are stable until the expiration date printed on the bottle and storage container when handled according to instructions. ..." Review of manufacturer's instructions for the BIO-RAD Liquichek Immunoassay Plus Control Levels 1, 2 and 3 revealed Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- STORAGE AND STABILITY This product will be stable until the expiration date when stored unopened at -20 to -70 degrees C. ..." Review of the laboratory's 2024 and 2025 temperature logs revealed an acceptable freezer temperature range of -20 to -70 degrees C which was not consistent with the manufacturer's specified range of -10 to -25 degrees C for storage of the VALIDATE linearity material. Documented freezer temperatures were outside the manufacturer's specified range of -10 to -25 degrees C for 193 of 208 days of testing from 1/1/24 to 10/31/24 and 150 of 173 days of testing from 12/1/24 to 7/22/25: 1. January 2024 - 22 of 23 days 2. February 2024 - 21 of 21 days 3. March 2024 - 21 of 21 days 4. April 2024 - 18 of 22 days 5. May 2024 - 19 of 22 days 6. June 2024 - 20 of 20 days 7. July 2024 - 21 of 22 days 8. August 2024 - 21 of 22 days 9. September 2024 - 18 of 18 days 10. October 2024 - 12 of 17 days 11. November 2024 - temperature logs missing 12. December 2024 - 19 of 21 days 13. January 2025 - 23 of 27 days 14. February 2025 - 19 of 20 days 15. March 2025 - 21 of 21 days 16. April 2025 - 21 of 27 days 17. May 2025 - 19 of 21 days 18. June 2025 - 18 of 21 days 19. July 2025 - 11 of 15 days. During interview at approximately 1:40 p.m., the TS confirmed that freezer temperatures were frequently outside the acceptable limits for storage of the VALIDATE linearity material during 2024 and 2025. The TS stated they were unable to locate the temperature logs for November 2024. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 7, 2021

Survey Type: Standard

Survey Event ID: T8H911

Deficiency Tags: D3031 D5411 D5429 D3031 D5411 D5429

Summary:

Summary Statement of Deficiencies D3031 RETENTION REQUIREMENTS CFR(s): 493.1105(a)(3) Analytic systems records. Retain quality control and patient test records (including instrument printouts, if applicable) and records documenting all analytic systems activities specified in 493.1252 through 493.1289 for at least 2 years. This STANDARD is not met as evidenced by: Based on the review of laboratory records and absence of documentation 10/7/21, the laboratory failed to retain manufacturer's QC(quality control) assay sheets for chemistry and endocrinology testing for 2 years. Findings: Review of 2019,2020, and 2021 laboratory QC records for the Roche Cobas Integra 400 and the Roche Cobas e411 revealed the laboratory failed to retain the BioRad Liquichek Immunoassay Plus Control assay sheets and the BioRad Liquichek Unassayed Chemistry Control assay sheets for the following lot numbers: 1. Liquichek Immunoassay Plus Control level 1 lot# 40971 and level 3 lot # 40973, expiration date: 6/30/20; 2. Liquichek Immunoassay Plus Control level 1 lot# 40991 and level 3 lot # 40993, expiration date: 12/31/20; 3. Liquichek Unassayed Chemistry Control level 1 lot # 56921 and level 2 lot #56922, expiration date: 1/31/21; 4. Liquichek Unassayed Chemistry Control level 1 lot # 56961 and level 2 lot# 56962, expiration date: 3/31/22. D5411 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(a) Test systems must be selected by the laboratory. The testing must be performed following the manufacturer's instructions and in a manner that provides test results within the laboratory's stated performance specifications for each test system as determined under 493.1253. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- This STANDARD is not met as evidenced by: Based on review of manufacturer's instructions, observation, and interview with the GS(General Supervisor) 10/7/21, the laboratory failed to follow manufacturer's instructions for storage of control material used on the Roche Cobas e411 for Estradiol testing. Findings: The BIORAD Liquichek Immunoassay Plus Control Level 1, 2, and 3 product insert state, "...STORAGE AND STABILITY...Once thawed, opened, and stored tightly capped at 2 to 8 degrees C(Celsius), this product will be stable as follows: All analytes: 14 days Except : Estradiol: 5 days..." During tour of the laboratory at approximately 4:20 p.m, the surveyor observed one open bottle of level 1 and one open bottle of level 3 BIORAD Liquichek Immunoassay Plus control, available for use. Both bottles were labeled with open date of 10/4/21 and expiration date of 10/18/21. At approximately 4:45 p.m., the GS confirmed the laboratory is using the BIORAD Liquichek Immunoassay Plus control for 14 days. D5429 MAINTENANCE AND FUNCTION CHECKS CFR(s): 493.1254(a)(1) For unmodified manufacturer's equipment, instruments, or test systems, the laboratory must perform and document maintenance as defined by the manufacturer and with at least the frequency specified by the manufacturer. This STANDARD is not met as evidenced by: Based on review of laboratory's procedures, review of the manufacturer's instructions, and review of maintenance records 10/7/21, the laboratory failed to perform and document maintenance procedures for the Roche Cobas Integra 400 analyzer at the frequency required by the manufacturer. Findings: The laboratory's "Quality Control Outline" procedure states, "II. Instrument Maintenance: Proper care and maintenance of the laboratory equipment is also a major component of the quality control program. Maintenance procedures, recommended by the manufacturer, are performed to ensure accuracy and precision on each instrument." The Cobas Integra 400 user manual states, "Replace electrode...You must replace electrodes when their expiration date is exceeded or when the ISE results deteriorate despite regular service..." The Cobas Integra 400 analyzer "Daily check list, maintenance log and General procedures" show a frequency of 30 days for Chloride electrode replacement and 180 days for Sodium and potassium electrode replacement. Review of Cobas Integra 400 maintenance records revealed the laboratory failed to replace the chloride and potassium electrodes at the frequency required for the following: a. Chloride electrode was replaced on 11/18/19; was due on 12/18/19, and not replaced again until 1/20/20; b. Chloride electrode was replaced on 4/20/20; was due on 5/20/20, and not replaced again until 6/16/20; c. Potassium electrode was replaced on 10/18/19; was due on 4/18 /20, and not replaced again until 9/24/20. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access